ArticleNucleic acids research2026
SEdb 3.0: a comprehensive super-enhancer database across multiple species.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Article
- Conservation of Long G4-rich (LG4) genomic enhancer regulations.BMC genomics · 2026Article
- Super-enhancer-driven KIAA1522 upregulation suppresses ferroptosis in hepatocellular carcinoma.Clinical and translational medicine · 2026Article
- Integrative Mapping of SNHG1 RNA-Chromatin Contacts onto the Cancer-Specific Super-Enhancer Landscape in HCT116 Colorectal Cancer Cells.International journal of molecular sciences · 2026Article
- BAF complexes maintain accessibility at stimulus-responsive chromatin and are required for transcriptional stimulus responses.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Super-enhancers (SEs) are key DNA cis-regulatory elements that play a central role in regulating tissue/cell-specific gene expression, thereby maintaining cellular identity and function. SEdb 3.0 (http://www.licpathway.net/sedb) provides an extensively updated resource of SEs and their regulatory annotations across multiple species. The current version of SEdb now curates 3 478 186 SEs from 5387 H3K27ac ChIP-seq samples across four species. Compared to SEdb 2.0, it has achieved a two-fold expansion in human and mouse SE entries while newly incorporating Arabidopsis thaliana and maize data, significantly enhancing both the database's scale and its utility in plant research. Furthermore, abundant (epi)genomic features have been added, such as enhancer RNAs (eRNAs), binding sites of transcription co-factors (TcoFs), and chromatin regulators (CRs). The inclusion of eRNAs provides insights into SE transcriptional activity. Mapping TcoF binding sites highlights their roles in mediating enhancer-promoter looping and stabilizing transcriptional complexes at SEs. The integration of CRs uncovers how SEs are associated with histone modifications and chromatin remodeling, which are critical for maintaining an open chromatin state. Collectively, these annotations not only reveal the diverse mechanisms by which SEs exert regulatory functions but also enable more detailed investigations into their biological significance and functional roles. Meanwhile, existing annotations have been substantially expanded, such as an approximately five-fold increase in transcription factor (TF) ChIP-seq data, a 2.3-fold rise in TF motifs, and a roughly 1.8-fold growth in SE-associated eQTL-gene regulatory pairs. SEdb 3.0 introduces two advanced inference strategies for associating genes with SEs. Moreover, two newly developed analysis tools are provided in SEdb 3.0, including SE blast alignment analysis and SE-driven core TF enrichment analysis. In summary, SEdb 3.0 represents a significant upgrade over SEdb 2.0, with a substantial expansion in SE coverage across multiple species, alongside enhanced functional annotations encompassing SE upstream/downstream regulatory information, thereby offering a more comprehensive and user-friendly platform for exploring the biological roles of SEs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.